Hana Muellerova

Medical Evidence Strategy Lead @阿斯利康

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2019 — Present

Medical Evidence Strategy Lead @阿斯利康

View department →

Cambridge, GB

MEDICAL EVIDENCE STRATEGY LEAD, COVID-19 vaccine and MaB (AZD7442)MEDICAL EVIDENCE STRATEGY LEAD, COPDHEAD, NOVELTY study: https://noveltystudy.com

EDUCATION

1988 — 1993

Charles University

Mgr., Pharmacy

1993 — 1996

Charles University

Ph.D., Clinical Pharmacy and Pharmacoepidemiology

1994 — 1995

Charles University

Pharm.D., Pharmacy

SKILLS

EpidemiologyClinical TrialsPublic HealthCopdClinical DevelopmentPharmaceutical IndustryOutcomes ResearchChronic Obstructive Pulmonary Disease (Copd)Medical WritingResearchRespiratory DiseasePharmacoepidemiologyPharmacovigilanceHealthcare

ABOUT HANA MUELLEROVA

Ever seeking new challenge / Whilst putting patients first / Through excellence in strategic planning and scientific execution Bold, decisive, ever learner, keenly investing in people to deliver differentiated business relevant evidence. Experienced RWE methodologist with strategic acumen within and beyond the RWE space. Scientist with a passion for improving lives of patients and delivering excellent public health solutions. Expert communicator striving to simplify scientific and RWE messages to diverse and broad audience. Ambassador of AstraZeneca in Pharma and Scientific and Clinical communities. Widely recognised expert in COPD epidemiology. Primary Author/Co-author of 90+ primary publications and numerous conference abstracts

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Hana Muellerova — Medical Evidence Strategy Lead at 阿斯利康 in London, GB | Unifers